StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Ardelyx (ARDX) Kept at Neutral by Cantor Fitzgerald, "Need More Commercial Visibility"
November 17, 2022 6:55 AM
Cantor Fitzgerald analyst Louis Chen maintains Ardelyx, Inc (NASDAQ: ARDX) at Neutral with a price target of $1.60, following a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Hot Comments
Next Articles
Ardelyx (ARDX) Director Mott Buys $1M in Stock Following Positive FDA Panel
November 17, 2022 4:14 PM
Ardelyx, Inc (ARDX) Stock 'Acting Poorly' Despite 50% Up Move - Citi
November 17, 2022 1:01 PM